BBVA
AKBA icon

Banco Bilbao Vizcaya Argentaria’s Akebia Therapeutics AKBA Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,000
Closed -$407K – 676
2020
Q2 		$407K Hold
30,000
– – 0.01% 594
2020
Q1 		$227K Hold
30,000
– – 0.01% 608
2019
Q4 		$189K Buy
+30,000
New +$143K 0.01% 683

Other funds holding AKBA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's AKBA Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Akebia Therapeutics (AKBA) in Q3 2020, closing a stake of 30,000 shares — an estimated $407K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in AKBA in Q4 2019 and held it in 3 quarters. The position peaked at $407K in Q2 2020. 164 funds tracked by Wall St. Rank hold AKBA as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Akebia Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 30,000 Akebia Therapeutics shares in Q3 2020, an estimated $407K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Akebia Therapeutics in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Akebia Therapeutics position peaked at $407K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.